INTERNATIONAL TELECOMMUNICATION UNION ITU is the leading United Nations agency for information and communication technologies, with the mission to connect the world. To achieve this, ITU manages the radio-frequency spectrum and satellite orbits at the international
Company Profile Founded in 1977, GMO is a global investment manager committed to delivering superior long-term investment performance and advice to our clients. We offer investment strategies and solutions where we believe we are positioned to
Your team At Swissblock, we are passionate about creating cutting-edge algorithmic trading strategies. Our institutional-grade trading solution delivers precision execution and deep market insights across multiple traditional financial markets. The quant and platform engineers of our
Salary Range:CHF169,400.00 - CHF314,600.00 Job Description Summary#LI-Hybrid Internal Title: TA Head, PKS Immunology Location: Basel We are seeking an accomplished and visionary scientific leader to join us as TA Head, PK Sciences (PKS) Immunology. In this
Salary Range:CHF122,500.00 - CHF227,500.00 BandLevel 5 Job Description Summary#LI-Hybrid Internal Title: Senior Principal Scientist or Associate Director Location: Basel, Switzerland The Modeling & Simulation group within PK Sciences is looking for a Principal Scientist to Associate
In short: We are looking for an experienced internal comms expert, skilled at telling stories through innovative mediums as we drive the next chapter of strategic communication at On. Reporting to the Global Head of Internal
At FNBO, our employees are the heart of our story—and we’re committed to their success! Please see below the details of this career opportunity and how it fits into our organization’s success. Summary of the Job:
Be the one building AI-powered experiences where they matter most. At Genesys, we help organizations create better customer experiences through AI-powered experience orchestration. Our platform connects people, systems, data and AI to help organizations deliver more
Salary Range:CHF169,400.00 - CHF314,600.00 BandLevel 7 Job Description Summary#LI-Hybrid Location: Basel, Switzerland We’re a team of dedicated international lawyers united by our purpose to reimagine medicine for patients in need and our drive to achieve together.
About Us Engelhart was founded in 2013 by BTG Pactual Group as a commodities trading company. Our business model is “asset light” and highly diversified – giving us the ability to adapt effectively and nimbly to
Buccellati is an Italian jewellery, high-jewellery and silversmithing Maison founded in 1919, admired in the world for its craftmanship and the uniqueness of its creations. Today, the Buccellati jewels stand out for their design and for
Location:Zurich, Zurich, Switzerland Job ID: R0139004 Date Posted:2026-08-03 Company Name:HITACHI ENERGY LTD Profession (Job Category):Sales, Marketing & Product Management Job Schedule: Full time Remote:No Job Description: The opportunity We are seeking a Senior Service Sales Manager
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Salary Range:CHF122,500.00 - CHF227,500.00 BandLevel 5 Job Description SummaryLocation: East Hanover NJ, US or Basel, Switzerland. This role will follow a hybrid working model. If based in US, please only apply to REQ-10080236 LI-#hybrid The Associate
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)